On July 13, 2012, Fortune published its 2012 Top 500 list for Chinese companies. Huadong Medicine Co.,Ltd.(hereinafter referred to as “Huadong Medicine”), under China Grand Enterprises, Inc., ranks 324th this year with RMB 11.131 billion of operating revenue. With stable performance, Huadong Medicine has made its way onto the list of top 10 Chinese pharmaceutical companies, while its No.1 ranking in the province remains unchanged.
LATEST NEWS
Grand Pharma brings heavyweight products to the World Health Expo
2023-04-12
Grand Pharma Recognized as a National Technology Innovation Demonstration Enterprise
2022-11-09
Globally innovative products Atectura® and Enerzair® developed by Grand Pharma officially enter the domestic market
2022-09-06
Accelerating Global Innovation, Opening Ceremony of Grand Pharma Optics Valley R&D Center and Extensive Intervention Production and R&D Platform
2022-08-24
SIR-Spheres® Yttrium-90 Microspheres Injections Introduced by Grandpharma Officially Launched in Chinese Market
2022-06-22
Yuanda Shuyang's New Production Base for Blood Products Officially Put into Operation
2022-04-15